News

Antiviral Medications for Treatment and Prevention of Influenza

Treatment of Influenza-like Illness

Oseltamivir (Tamiflu® - oral) and Zanamivir (Relenza® - inhaled) are neuraminidase inhibitors which block the exit of influenza virus from respiratory cells and thus prevent further replication of the virus.

Despite debate about oseltamivir efficacy studies[i], neuraminidase inhibitors are still recommended for treatment of people at high risk of complications from influenza (adults aged 65+, pregnant women and women up to 4 weeks post-partum, indigenous people...

Read more

Electronic Referrals: Physicians can now refer to The Royal directly from EMR

Family physicians and nurse practitioners can now submit referrals to certain mental health programs at The Royal directly from their Electronic Medical Record (EMR) systems. This EMR-based referral process can be used to refer patients to the following programs:

• Mood and Anxiety Disorders
• Integrated Schizophrenia Recovery
• Forensic Mental Health
• Dual Diagnosis
• Substance Use and Concurrent Disorders
• Short Term Talk Therapy (IASP program led by The Royal and delivered in collaboration with community...

Read more

LGBTQ+ Patients: Links to Clinical and Care Practices, Learning Opportunities

The health needs of LGBTQ+ people are unique. They can be affected by a range of social, structural and behavioural factors as well as deep-rooted stigma and discrimination. Barriers in accessing care may also be compounded by other factors such as racial status, education and income level, geographic isolation, immigration status, knowledge and cultural beliefs.

Transgender individuals may also face additional issues.  Unique health concerns and needs related to hormone replacement therapy,...

Read more

Update: Chlamydia Follow-up Practice Changes

Chlamydia is the most frequently reported of all reportable infections to Ottawa Public Health (OPH). The incidence in 2018 was 380 infections per 100,000 population, corresponding to 3,806 cases - four-times the next most commonly reported sexually transmitted or bloodborne infection (STBBI). Chlamydia rates are increasing in Ottawa with the highest rate in females aged 20-24 years.

In September 2018, the Ottawa Public Health case management procedure on chlamydia follow-up was modified based...

Read more

Vaccine Complacency: Quick Links to Resources to Support Working with Vaccine-Hesitant Parents

Vaccine complacency can put communities at risk by lowering immunization rates.

The Ontario Medical Association is warning that there is an increase in the number of parents in Ontario seeking non-medical exemptions from the Immunization of School Pupils Act. This trend has not been observed in Ottawa, but if you are hearing concerns about vaccines from patients who are hesitant to vaccinate their children, OPH has resources to help you reassure parents and to update immunizations for children...

Read more